Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

PaxVax Announces the Initiation of Phase 2b Trial for its Chikungunya Vaccine

americanpharmaceuticalreviewApril 27, 2018

Tag: trial , PaxVax

PharmaSources Customer Service